RespireRx Pharmaceuticals
(OTC) RSPI
RespireRx Pharmaceuticals Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$1.82M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RSPI News
RSPI: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout RespireRx Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
6
CEO
Arnold S. Lippa, PhD
Website
www.respirerx.comHeadquarters
Glen Rock, NJ 07452, US
RSPI Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
19%
Return on Capital
13%
Return on Assets
-92%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.58M
EBITDA
$1.65M
Operating Cash Flow
$143.91K
Capital Expenditure
$5.00
Free Cash Flow
$143.90K
Cash & ST Invst.
$88.00
Total Debt
$2.71M
RespireRx Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2
N/A
Net Income
$395.50K
+14.3%
EBITDA
$76.66K
+80.3%
Quarterly Fundamentals
Net Cash
$2.77M
-8.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$2.78M
+8.8%
Return on Assets
-92.30%
N/A
Return on Invested Capital
13.49%
N/A
Free Cash Flow
$100.96K
-44.4%
Operating Cash Flow
$100.96K
-44.4%